Products

Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.

See all 1 product →

About Trially AI

Trially AI is a healthcare artificial intelligence company focused on revolutionizing clinical trial recruitment. Their AI-powered platform aims to streamline clinical research and accelerate the development of advanced therapies. The platform integrates with existing Electronic Health Record (EEHR), Clinical Trial Management System (CTMS), Customer Relationship Management (CRM), or Health Information Exchange (HIE) systems to automate patient identification and recruitment.

For physicians, Trially AI’s platform, including its ‘Margo’ AI agent, is designed to significantly reduce the administrative burden associated with clinical trial enrollment. It automates the process of identifying eligible patients from EHR data with approximately 95% accuracy, reducing manual chart review time by up to 90%. This allows physicians and their staff to focus on patient care rather than time-consuming screening processes. The platform also aims to improve patient access to potentially life-saving treatments by efficiently matching them with relevant trials they might otherwise miss.

Trially’s offerings include Trially Match, which uses large language model (LLM) agents to analyze structured and unstructured medical data for instant patient-to-trial matching; Trially Connect, which utilizes the Margo AI agent for outreach and pre-screening to convert matched patients into participants; and Trially Intelligence, a pipeline radar that provides proactive alerts for suitable trials and instant feasibility analytics. The platform is designed to be fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, IRB, and ISO 27001 regulations, ensuring data security and privacy.

Focus Areas

clinical trial recruitment artificial intelligence patient matching patient engagement data analysis EHR integration LLM agents

Business Intelligence

Key InvestorsFlyover Capital, Alpaca, Atria, Blu Ventures, Looking Glass Capital, Redbud, The Council, Gaingels
PartnershipsClinTrial Research, athenahealth, CRIO
TechnologyAI-powered, HIPAA-compliant LLM agents, cloud-native, integrates with EHR, CRM, CTMS, HIE systems
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

Clinical Trial Recruitment
Trially AI specializes in revolutionizing clinical trial recruitment by automating patient identification and engagement, aiming to enroll patients up to 4x faster. They address the industry-wide problem of trial delays due to recruitment failures, which affect 86% of trials and cost millions daily.
Artificial Intelligence & LLM Agents
The company leverages advanced AI, including HIPAA-compliant Large Language Model (LLM) agents, to analyze both structured and unstructured EHR data (such as physician notes, demographics, diagnoses, medications, imaging, labs, and pathology reports) with approximately 95% accuracy. Their Margo AI Agent automates patient conversion, including pre-screening, scheduling, and reminders via SMS and voice.
Patient Matching
Trially Match instantly and precisely matches patients to trials and trials to patient populations. This high-precision matching leads to a significant reduction in screen failure rates (up to 73%) and identifies hundreds of high-quality patient candidates in real-time.
Patient Engagement
Through Trially Connect and the Margo AI Agent, the platform engages patients with automated outreach, scheduling appointments, and sending reminders, transforming qualified candidates into enrollments.
Data Analysis & EHR Integration
Trially integrates directly with EHR, CRM, CTMS, or HIE systems to analyze 100% of EHR data in real-time. This enables real-time interpretation and summaries of rich medical data, reducing manual chart review time by up to 90%.
Feasibility & Analytics
Trially Intelligence provides real-time feasibility analytics and proactive alerts for studies that match a site's patient population. This allows for data-driven decision-making, helping sites assess population fit before a trial begins and generate exact patient counts for sponsors.
Physician Tip

Trially AI empowers physicians by reducing the administrative burden of clinical trial recruitment, allowing them to focus on patient care. The platform proactively identifies high-quality, trial-eligible candidates directly within the EHR, highlighting why patients qualify and when they are scheduled to visit. This enables more informed and timely conversations with patients already in their care, facilitating referrals and increasing the likelihood of successful enrollment. Trially's explainable AI ensures transparency, allowing physicians to understand the rationale behind patient matches.

Trially AI offers pre-built connectors for seamless integration with over 16 EHRs (including Epic, Oracle Cerner, NextGen, and AthenaHealth), CTMS, CRM (e.g., Salesforce, HubSpot), or other patient lists. The platform is designed to keep existing workflows intact and is fully compliant with HIPAA, SOC 2, IRB, FDA 21 CFR Part 11, and ISO 27001 standards, ensuring data privacy and security with features like AES-256 encryption and role-based access control.

Products by Trially AI

1 product in the directory

Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.

What the Web Says

Trially AI is a platform designed to revolutionize clinical trial patient recruitment and management using AI, including HIPAA-compliant LLM agents. It aims to address the significant delays and costs associated with traditional clinical trial recruitment by instantly matching patients to trials, engaging them through automated outreach, and providing real-time feasibility analytics. The platform integrates with existing EHR, CTMS, CRM, and other systems. Trially AI has secured significant seed funding to accelerate its adoption across research sites, sponsors, and CROs.

Overall: Positive

Strengths

  • Multiplies clinical trial enrollment (2-6x more patients enrolled per month).
  • Reduces manual chart review time by approximately 90%.
  • Achieves high accuracy in patient-to-trial matching (~95%).
  • Decreases screen failure rates by roughly 73%.
  • Offers a significant return on investment (10x ROI for Trially Connect).
  • HIPAA, SOC 2, IRB, FDA 21 CFR Part 11, and ISO 27001 compliant.

Limitations

  • No readily available negative product reviews from independent sources like G2, Glassdoor, Capterra, or Reddit.
  • Limited public information on company culture or employer reviews.
  • Some general concerns about AI tools in healthcare regarding data privacy and ethical considerations, though Trially emphasizes its compliance.

Based on reviews from: Trially AI Official Website, G2, Glassdoor, Capterra, Reddit, Redbud VC, GlobalData, Ward and Smith, P.A.

Last updated: 2026-09-04

Videos

News, demos, and interviews about Trially AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Trially AI →

View all on YouTube

Press & Coverage

Business Wire
Trially AI Seed Round Secures $4.7M and Launches u201cMargou201d to Solve Clinical Trial Recruitment Bottleneck
Trially AI announced a $4.7 million seed funding round and the launch of Margo, an agentic AI solution designed to significantly increase clinical trial enrollment by converting patient matches into participants. The platform aims to address the critical bottleneck of patient recruitment, which delays 86% of clinical trials.
2025-09
Startland News
Trially secures $4.7M seed round, launches 'Margo' AI solution to clear patient bottleneck
Kansas City startup Trially secured $4.7 million in a seed funding round led by Flyover Capital, launching its 'Margo' AI solution to accelerate clinical trial recruitment. The platform uses HIPAA-compliant LLM agents to analyze medical data, instantly matching and engaging patients with suitable trials.
2025-09
Clinical Trials Arena
Trially raises $4.7m to enhance trial recruitment with AI
Trially has successfully raised $4.7 million in seed funding to advance its AI solution, Margo, which aims to improve clinical trial enrollment rates. The company's platform utilizes AI to analyze unstructured medical data, match patients to trials, and engage them for enrollment, addressing a major cause of trial delays.
2025-09
Pulse 2.0
Trially AI: $4.7 Million Raised For AI-Based Clinical Trial Recruitment Platform - Pulse 2.0
Trially, an AI-powered platform for clinical trial recruitment, announced a $4.7 million funding round to support the launch of Margo, its new AI solution. Margo aims to boost trial enrollment by efficiently converting patient matches into participants, significantly reducing the time and resources typically spent on manual chart reviews.
2025-09
Trially AI Blog
AI and Innovation in Clinical Trials: A Point-by-Point Analysis of Trially's LLM-Powered Enrollment and Optimization Strategy
This analysis details Trially's strategy for leveraging Large Language Models (LLMs) and AI agents to address challenges in clinical trial recruitment and optimization. The platform aims to improve patient matching accuracy, reduce screen failure rates, and enhance trial planning through data-driven insights.
2025-11
Trially AI Blog
How LLMs Are Changing Clinical Trial Recruitment: Key Insights from the Latest Cohort Study - Trially AI
A new publication, 'Cohort Discovery: A Survey on LLM-Assisted Clinical Trial Recruitment,' examines how AI-enabled tools, including Trially's platform, are transforming patient recruitment. Trially's approach focuses on real-time interpretation of rich medical data to instantly surface high-quality patient matches and reduce screen failure rates.
2025-07
Trially AI Blog
Clinical Trial Operations, AI and Monitoring Risk in Real Time - Trially
This article discusses how AI-driven monitoring, like Trially's platform, can significantly reduce clinical trial delays by matching patients with high accuracy and boosting enrollment. Trially's product is compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, IRB, and ISO 27001 regulations, ensuring data security and privacy.
2026-08
Digital Health KC
Unlocking Faster Cures: Trially AI Revolutionizes Clinical Trials - Digital Health KC
An interview with Trially co-founder Kyle McAllister highlights how their AI platform is revolutionizing clinical trials by streamlining patient identification and engagement. The solution leverages artificial intelligence to analyze electronic health records (EHRs) and efficiently match patients to trials, aiming for faster drug development and wider access to treatments.
2024-05

Frequently Asked Questions

Trially AI utilizes advanced AI and machine learning algorithms to analyze vast datasets, including EHRs, to identify eligible patients for clinical trials more efficiently. This approach helps to overcome common recruitment challenges by proactively matching patients to suitable trials based on specific criteria, thereby accelerating the recruitment process and reducing study timelines.
Trially AI offers a suite of products designed for precision patient matching and enhanced engagement. These include AI-powered patient identification tools that integrate with existing EHR systems, as well as platforms for personalized patient outreach and communication to improve retention throughout the trial lifecycle.
Trially AI prioritizes data privacy and security, adhering to stringent regulatory standards such as HIPAA and GDPR. Our platforms incorporate robust encryption, access controls, and de-identification techniques to protect sensitive patient information, ensuring secure and compliant integration with electronic health records.
Trially AI employs LLM agents in a supervised capacity, primarily for tasks like initial data synthesis and generating draft communications, with human oversight for validation. We implement rigorous testing and bias detection protocols to ensure the accuracy and fairness of our LLM outputs, continuously refining models to mitigate potential biases and enhance reliability.
Trially AI offers flexible pricing models tailored to the specific needs and scale of healthcare organizations, often based on subscription tiers or per-trial agreements. We provide comprehensive support, including implementation assistance, ongoing technical support, and strategic partnerships to co-develop customized AI solutions for clinical research.
Trially AI is committed to long-term stability through continuous innovation, strategic investments in R&D, and fostering strong relationships with our clients and partners. We maintain a robust financial foundation and a dedicated team of experts to ensure the ongoing reliability and evolution of our AI solutions for clinical trials.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.